Article History
Received: 16 April 2021
Accepted: 17 July 2021
First Online: 12 August 2021
Declarations
:
: As of the date of submission of this manuscript, H. Xiang, A. Ahene, and H. Collins were employed by Five Prime Therapeutics, Inc. and each owned share of capital stock of Five Prime Therapeutics, Inc.. L. Liu and Y. Gao declare no potential conflicts of interest.
: All studies were conducted in accordance with the Declaration of Helsinki and Guidelines for Good Clinical Practice; approval from Institutional Review Boards or Independent Ethics Committees was obtained for each trial [CitationRef removed, CitationRef removed]. Written informed consent was obtained from all trial participants.
: Written informed consent was obtained from all trial participants.
: Patients signed informed consent regarding publishing their data.